Provided by Tiger Trade Technology Pte. Ltd.

Mind Medicine (MindMed) Inc.

15.02
0.0000
Volume:- -
Turnover:30.63M
Market Cap:1.48B
PE:-7.60
High:15.02
Open:15.02
Low:15.02
Close:15.02
52wk High:15.29
52wk Low:4.70
Shares:98.51M
Float Shares:91.33M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9758
EPS(LYR):-1.5424
ROE:-85.59%
ROA:-33.95%
PB:11.33
PE(LYR):-9.74

Loading ...

Company Profile

Company Name:
Mind Medicine (MindMed) Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company also develops MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. The company is headquartered in New York, New York.